Causal association of genetically predicted 1400 blood metabolites with inflammatory bowel disease risk: A Mendelian randomization study

Read full text Summarise with VIRAT
Authors: Lin Huang, Wenzhe Hao, Xiaoli Fang, Jianmin Wang, Yang Shi, Zilong Li, Hao Ye, Ming Li
Cited by: 0
References: 64

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We utilized an unbiased 2-sample Mendelian randomization approach to investigate the potential causal relationship between 1400 human blood metabolites and the risk of inflammatory bowel disease (IBD). Exposure data were sourced from the largest metabolome-based genome-wide association study (mGWAS), which included 8299 individuals from Canada. The results were primarily derived from a meta-analysis of genome-wide association studies (GWAS) involving 25,042 patients and 34,915 healthy controls, with additional data from a European GWAS database consisting of 12,882 IBD cases and 21,770 healthy controls. The main analysis employed the inverse variance weighted model, alongside Mendelian randomization-Egger regression and the weighted median method for supplementary analysis. Heterogeneity and pleiotropy sensitivity analyses were also conducted to ensure result robustness. The replication analysis of the inverse variance weighted (IVW) method identified 53 blood metabolites significantly associated with IBD risk (P

Fields of Study & Subjects

Inflammatory Bowel Disease Genetic Associations and Epidemiology Gut microbiota and health

Publication details

Journal / source
Medicine
Volume
105
Issue
13
Pages
e48132–e48132
Publication date
27 March 2026
Language
EN